Cambia
NDC Package 50192-113-01
Package Information
Cambia is diclofenac is used to relieve pain from various conditions. Marketed by Nautilus Neurosciences, Inc., this product is identified by NDC 50192-113 and is authorized under FDA application NDA022165.
Identification & Billing
- RxCUI: 859063 - diclofenac potassium 50 MG Powder for Oral Solution
- RxCUI: 859063 - Diclofenac K+ 50 MG Powder for Oral Solution
- RxCUI: 859063 - Diclofenac Pot 50 MG Powder for Oral Solution
- RxCUI: 859066 - CAMBIA 50 MG Powder for Oral Solution
- RxCUI: 859066 - diclofenac potassium 50 MG Powder for Oral Solution [Cambia]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50192 - Nautilus Neurosciences, Inc.
- 50192-113 - Cambia
- 50192-113-01 - 50 mg in 1 PACKET
- 50192-113 - Cambia
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (50192-113). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50192-113-01 identifies a specific commercial package of 50 mg in 1 packet of Cambia, labeled by Nautilus Neurosciences, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nautilus Neurosciences, Inc. on April 20, 2010. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
Diclofenac is used to relieve pain from various conditions. This form of diclofenac is used to treat migraine headaches. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever.
How is this Nautilus Neurosciences, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50192011301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.